<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, this study details the process of designing an optimized topical 4-MU formulation that efficiently and effectively results in hyaluronan synthesis inhibition in normal mice skin. These findings provide a foundation for future study into, and treatment of, pathologic HA overexpression in common dermatologic disorders and malignancy.</p>
